Latest News
The nightingales of MSWA’s nursing generation
10th May 2019
International Nurses Day, Sunday May 12, is an opportunity to celebrate the fantastic work our MSWA nurses do for people living with MS and other neurological conditions.
Read More
New drug approved to treat children with MS
2nd May 2019
The Therapeutic Goods Administration (TGA) has approved Gilenya (fingolimod) for the treatment of children and adolescents 10-17 years old with relapsing forms of multiple sclerosis.
Read More
MSWA partners with the West Coast Eagles
1st May 2019
We’re excited to be partnering with West Coast Eagles to support the WA community. Read about the important work that we do and get a chance to be an Eagle for a day!
Read More
European Medicines Agency (EMA) - Review underway for MS drug Lemtrada®
15th April 2019
Following a warning late last year, European neurologists have been cautioned on the use of the MS treatment Lemtrada; while the EMA undertakes their review of side effects in some European patients.
Read More
